Device Trial Radar · NCT06689423
Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,268
Actual
Start
Nov 1, 2024
Primary completion
Dec 18, 2025
Study completion Dec 18, 2025
Sponsor
- Lead sponsor
- Credo Diagnostics Biomedical Pte. Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medical College of Wisconsin
- First posted
- Nov 14, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to demonstrate the clinical performance of the VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay in detecting SARS-CoV-2, Flu A, Flu B and RSV in symptomatic population. The primary aim is to determine the PPA/NPA against a comparator assay. The secondary aim is to determine the diagnostic sensitivity, specificity, PPV and NPV against the standard-of-care test. Each subjects will be asked to provide both nasal swab (NS) and nasopharyngeal swab (NPS) for testing purposes.
Conditions
- SARS-CoV-2
- COVID-19
- RSV
- Influenza
Interventions
Credo POCT DeviceDevice
Testing Credo's POCT device for respiratory viruses detection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive percent agreement(PPA) and Negative percent agreement (NPA)Time frame: In 7 days after specimen collection
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Credo Diagnostics Biomedical Pte Ltd. Taiwan Branch
New Taipei City, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.